Blood levels of leukotrienes (LTC 4, D 4, E 4, B 4) and synthesis of leukotriene B 4 by peripheral leukocytes in children with acute a and B hepatitis

Turkish Journal of Pediatrics

Volumn 41, Issue 4, 1999, Pages 457-465

  Kasirga, Erhun ^a,b   Çoker, Işil ^a,c   Aydoǧdu, Sema ^a,b   Yaǧci, Raşit V ^a,b   Taneli, Baha ^a,b   Gousseinov, Afig ^a,b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c Social Security Teaching Hospital   (Turkey)

Author keywords

Acute viral hepatitis; Leukotrienes; Lipid mediators

Indexed keywords

LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4;

ARTICLE; BIOSYNTHESIS; BLOOD; CHILD; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; LEUKOCYTE; MALE; METABOLISM;

CHILD; FEMALE; HEPATITIS A; HEPATITIS B; HUMANS; LEUKOCYTES; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENES; MALE;

EID: 0033205255     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Brain SD, Williams TJ. Leukotrienes and inflammation. Pharmacol Ther 1990; 46: 57-66.
2. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323: 645-655.
3. Keppler D, Hagman W, Rapp S, Denzlinger C, Koch HK. The relation of leukotrienes to liver injury. Hepatology 1985; 5: 883-891.
4. William R, Henderson J. The role of leukotrienes in inflammation. Ann Intern Med 1994; 121: 684-697.
5. Bisgaard H. Sulphidoleukotrienes in human allergic diseases. Dan Med Bull 1989; 36: 142-159.
6. Ford-Hutchinson AW. Leukotriene B4 in inflammation. Crit Rev Immunol 1990; 10: 1-12.
7. Meng XJ, Wang JL. Arachidonic acid metabolism in galactosamine/endotoxin induced acute liver injury in rats. J Tongji Med Univ 1994; 14: 169-172.
8. Hagmann W, Steffan AM, Kirn A, Keppler D. Leukotrienes as mediators in frog virus 3-induced hepatitis in rats. Hepatology 1987; 7: 732-736.
9. Wettstein M, Gerok W, Haussinger D. Hypoxia and CC14 induced liver injury, but not acidosis, impair metabolism of cysteinyl leukotrienes in perfused rat liver. Hepatology 1990; 11: 866-873.
10. Shiratori Y, Tanaka M, Umihara J, Kawase T, Shiina S, Sugimoto T. Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide-activated macrophages. J Hepatol 1990; 10: 51-61.
11. Nagai H, Kitagaki K, Miura T, Shimazawa T, Koda A. Effect of a newly synthesized leukotriene antagonist, (E)-2,2diethyl-3′-2-2-(4-isopropyl) thiazolyl ethenyl succinanilic acid (MCI-826), on immunological liver injury and nephritis in mice. Prostaglandins Leukot Essent Fatty Acids 1992; 47: 51-57.
12. Kepplerr D, Muller M, Klunemann C, et al. Transport and in vivo elimination of cysteinyl leukotrienes. Adv Enzyme Regul 1992; 32: 107-116.
13. Wettstein M, Noé B, Häussinger D. Metabolism of cysteinyl leukotrienes in the perfused rat liver: the influence of endotoxin pretreatment and the cellular hydration state. Hepatology 1995; 22: 235-240.
14. Kawada N, Ueda N, Mizoguchi Y, et al. Increased 5-lipoxygenase activity in massive hepatic cell necrosis in the rat correlates with neutrophil infiltration. Hepatology 1992; 16: 462-468.
15. Otomo Y, Kanda Y, Yoshino Y, Otsuka T. Production of leukotrienes in rat Kupffer cells and hepatocytes by various inducers. Nippon Geka Gakkai Zasshi 1993; 94: 234-241.
16. Fukai F, Suzuki Y, Nishizawa Y, Katayama T. Transcellular biosynthesis of cysteinyl leukotrienes by Kupffer cell-hepatocyte cooperation in rat liver. Cell Biol Int 1996; 20: 423-428.
17. Maxwell WJ, Keating JJ, Hogan FP, Kennedy NP, Keeling PW. Prostaglandin E2 and leukotriene B4 synthesis by peripheral leukocytes in alcoholics. Gut 1989; 30: 1270-1274.
18. Mosin VI, Yagoda AV. Synthesis of eicosanoids by circulating mononuclears in healthy people and in patients with liver cirrhosis. Hepatogastroenterology 1992; 39: 248-251.
19. Laffi G, Carloni V, Baldi E, et al. Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis. Gastroenterol 1993; 105: 170-177.
20. Rola-Pleszczynski M, Pouliot C, Turcotte S, Pignol B, Braquet P, Bouvrette L. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells. J Immunol 1988; 140: 3547-3552.
21. Zhou W, McCollum MO, Levine BA, Olson MS. Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology 1992; 16: 1236-1240.
22. Pearson JM, Bailie MB, Fink GD, Roth RA. Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration. Toxicology 1997; 121: 181-189.
23. Toth CA, Thomas P. Liver: endocytosis and Kupffer cells. Hepatology 1992; 16: 255-266.
24. Mowat AP. Liver Disorders in Childhood. London: Butterworth-Heinemann Ltd; 1994; 97-115.
25. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991; 13: 364-375.
26. Claesson HE, Odlander B, Jakobsson PJ. Leukotriene B4 in the immune system. Int J Immunopharmacol 1992; 14: 441-449.